Form 4 for PRLB Proto Labs Inc
Accepted 2022-09-13 00:00:00 ET · period of report 2022-09-09 · accession 0001437749-22-022332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-13 | 2022-09-09 | PRLB | Ryaboy Oleg | CTO | A - Grant | $0.00 | +9,361 | 9,361 | New | $0 |
| D | 2022-09-13 | 2022-09-09 | PRLB | Ryaboy Oleg | CTO | A - Grant | $0.00 | +6,307 | 6,307 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-09 | A | A | 9,361 | $0.00 | 9,361 | D | — | — | (F1) The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2023. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-09-09 | A | A | 6,307 | $0.00 | 6,307 | D | $40.06 · — to 2032-09-09 | 6,307 Common Stock | (F2) The stock option vest as to 25% of the shares in four annual installments beginning on February 13, 2023. |